Timing of Bridge Plate Removal and Distal Radius Fracture Outcomes
NCT ID: NCT05578612
Last Updated: 2024-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-01-05
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bridge Plate Removal at 6-8 Weeks Postoperatively
Participants will undergo dorsal spanning bridge plate fixation per standard technique. Patients in the experimental group will return to the operative room for removal of the bridge plate at Week 6-8. Patients will begin the standardized postoperative rehabilitation protocol immediately following bridge plate removal on Week 6-8.
Dorsal Spanning Bridge Plate Fixation
Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Dorsal Spanning Bridge Plate Removal
Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Bridge Plate Removal at 12-14 Weeks Postoperatively
Participants will undergo dorsal spanning bridge plate fixation per standard technique. Patients in the control group will return to the operating room for removal of the bridge plate at Week 12-14. Patients will begin the standardized postoperative rehabilitation protocol immediately following bridge plate removal on Week 12-14.
Dorsal Spanning Bridge Plate Fixation
Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Dorsal Spanning Bridge Plate Removal
Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dorsal Spanning Bridge Plate Fixation
Dorsal spanning bridge fixation will be performed by board-certified orthopedic surgeons per standard technique.
Dorsal Spanning Bridge Plate Removal
Dorsal spanning bridge removal will be performed by board-certified orthopedic surgeons per standard technique.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18 years or greater
3. Capacity to provide informed consent
Exclusion Criteria
2. Bilateral distal radius fractures (prevents accurate measurement of postoperative range of motion and strength of the injured extremity without a normal contralateral extremity for comparison)
3. Pathologic fractures
4. Patients that will be unable to complete the necessary follow up, including incarcerated patients
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali Azad, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-01142
Identifier Type: -
Identifier Source: org_study_id